Clearmind Medicine Inc. Common Shares (CMND)
Stock · NASDAQ · Health Care
$1.76as of 8/28/2026
Price chart
Open in TradingViewActive signals
No technical signal is currently active for this symbol.
Support level
$1.57
Industry
Biotechnology: Pharmaceutical Preparations
About CMND
Clearmind Medicine Inc., a clinical stage pharmaceutical company, develops novel psychedelic medicines to treat under-served health problems. The company develops treatments for alcohol use disorders, binge drinking, and eating disorders, as well as weight loss, obesity, and metabolic syndrome, anxiety disorders, post-traumatic stress disorder, depression, and treatment resistant depression. It develops MEAI compound…
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Website
- www.clearmindmedicine.com
Fundamentals
- 1-day range
- $1.82$1.89
- Market cap
- $1.78M
- P/E (trailing)
- —
- P/E (forward)
- —
- EPS (trailing)
- $-175.92
- Dividend yield
- —
- Beta
- -1.18
- Avg. volume
- 2.02M
52-week range
$1.43$524
Clearmind Medicine Inc. Common Shares Competitors
Chosen by industry and closest market cap.
- CMNDClearmind Medicine Inc. Common Shares$1.76▼ 2.76%Market cap $1.78MP/E —$1.43$524
- MTNBMatinas Biopharma Holdings Inc. Common Stock$0.1966▼ 1.70%Market cap $1.72MP/E —$0.178$2.14
- OGENOragenics Inc. Common Stock$0.5296▼ 0.08%Market cap $2.45MP/E —$0.4801$1.45
- BDRXBiodexa Pharmaceuticals plc American Depositary Shs$0.8351▼ 7.21%Market cap $1.10MP/E —$0.8303$59.4
- CDTCDT Equity Inc. Common Stock$1.69▼ 10.37%Market cap $2.54MP/E —$1.62$2,928
- SBFMSunshine Biopharma Inc. Common Stock$1.16▼ 8.66%Market cap $2.97MP/E —$1.01$24.3
- SXTP60 Degrees Pharmaceuticals Inc. Common Stock$1.03▼ 2.83%Market cap $3.28MP/E —$1.01$8.62
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| CMND Clearmind Medicine Inc. Common Shares | $1.78M | — | $1.76 | ▼ 2.76% | $1.43$524 |
| MTNB Matinas Biopharma Holdings Inc. Common Stock | $1.72M | — | $0.1966 | ▼ 1.70% | $0.178$2.14 |
| OGEN Oragenics Inc. Common Stock | $2.45M | — | $0.5296 | ▼ 0.08% | $0.4801$1.45 |
| BDRX Biodexa Pharmaceuticals plc American Depositary Shs | $1.10M | — | $0.8351 | ▼ 7.21% | $0.8303$59.4 |
| CDT CDT Equity Inc. Common Stock | $2.54M | — | $1.69 | ▼ 10.37% | $1.62$2,928 |
| SBFM Sunshine Biopharma Inc. Common Stock | $2.97M | — | $1.16 | ▼ 8.66% | $1.01$24.3 |
| SXTP 60 Degrees Pharmaceuticals Inc. Common Stock | $3.28M | — | $1.03 | ▼ 2.83% | $1.01$8.62 |
P/E shows — for peers not currently carrying a live signal of their own.
Latest news
- Clearmind Medicine Makes Clinical Progress in Alcohol Addiction Treatment TrialBenzinga · 8/13/2026
- What's going on in today's pre-market sessionChartMill · 8/3/2026
Insider Activity
Insider Actions →Acquired
2.16M
Disposed
252.6K
- HRT FINANCIAL LP · June 16, 2026 · Sale22.1K @ $3.31
- HRT FINANCIAL LP · June 15, 2026 · Sale3.2K @ $3.32
- HRT FINANCIAL LP · June 12, 2026 · Sale2.1K @ $3.36
- HRT FINANCIAL LP · June 11, 2026 · Sale225.2K @ $0.123
- HRT FINANCIAL LP · June 10, 2026 · Buy2.16M @ $0.153
See the full, filterable feed with live charts on the MarketWall dashboard.